Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation (vol 71, pg 237, 2011)

被引：0
|
作者：
Atar, D. [1 ]
Banach, M. [2 ]
Ehrlich, J. R. [3 ]
Fedida, D. [4 ,5 ]
Lip, G. Y. H. [6 ]
Savelieva, I. [7 ]
机构：
[1] Univ Oslo, Div Cardiol, Oslo, Norway
[2] Med Univ Lodz, Dept Hypertens, Lodz, Poland
[3] Goethe Univ Frankfurt, Div Cardiol, Frankfurt, Germany
[4] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada
[5] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada
[6] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, W Midlands, England
[7] St Georges Univ London, Div Cardiac & Vasc Sci, London, England
来源：
DRUGS | 2011年 / 71卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：381 / 381
页数：1
相关论文
共 50 条
  • [1] Intravenous Vernakalant A Review of its Use in the Management of Recent-Onset Atrial Fibrillation
    Duggan, Sean T.
    Scott, Lesley J.
    DRUGS, 2011, 71 (02) : 237 - 252
  • [2] Erratum to Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation
    S. T. Duggan
    L. J. Scott
    Drugs, 2011, 71 (3) : 381 - 381
  • [3] Intravenous vernakalant: A guide to its use in recent-onset atrial fibrillation
    Drugs & Therapy Perspectives, 2011, 27 (8) : 6 - 10
  • [4] Spotlight on Intravenous Vernakalant in Recent-Onset Atrial Fibrillation
    Duggan, Sean T.
    Scott, Lesley J.
    DRUGS & AGING, 2011, 28 (06) : 501 - 504
  • [5] Spotlight on Intravenous Vernakalant in Recent-Onset Atrial Fibrillation
    Sean T. Duggan
    Lesley J. Scott
    Drugs & Aging, 2011, 28 : 501 - 504
  • [6] Intravenous VernakalantA Review of its Use in the Management of Recent-Onset Atrial Fibrillation
    Sean T. Duggan
    Lesley J. Scott
    Drugs, 2011, 71 : 237 - 252
  • [7] Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation
    Pohjantahti-Maaroos, Hanna
    Hyppola, Harri
    Lekkala, Maria
    Sinisalo, Emma
    Heikkola, Antti
    Hartikainen, Juha
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2019, 8 (02) : 114 - 120
  • [8] Vernakalant - a promising therapy for conversion of recent-onset atrial fibrillation
    Naccarelli, Gerald V.
    Wolbrette, Deborah L.
    Samii, Soraya
    Banchs, Javier E.
    Penny-Peterson, Erica
    Stevenson, Robert
    Gonzalez, Mario D.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (05) : 805 - 810
  • [9] Propafenone Versus Vernakalant for Conversion of Recent-Onset Atrial Fibrillation
    Conde, Diego
    Pablo Costabel, Juan
    Aragon, Martin
    Lambardi, Florencia
    Klein, Andres
    Corrales Barbosa, Andrea
    Trivi, Marcelo
    Giniger, Alberto
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (06) : 377 - 380
  • [10] Predictors of Conversion of Recent-Onset Atrial Fibrillation Treated with Vernakalant
    Costabel, Juan P.
    Lambardi, Florencia
    Aragon, Martin
    Campos, Roberto
    Urdapilleta, Marcela
    Ariznavarreta, Paula
    Vergara, Juan M.
    Conde, Diego
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (02): : 196 - 200
12345